These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 26664666)

  • 1. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.
    Thavorn K; Coyle D
    Ont Health Technol Assess Ser; 2015; 15(19):1-58. PubMed ID: 26664666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations.
    van Katwyk S; Coyle D; Cooper C; Pussegoda K; Cameron C; Skidmore B; Brener S; Moher D; Thavorn K
    Liver Int; 2017 Jun; 37(6):851-861. PubMed ID: 27699993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
    Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
    Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.
    Brener S
    Ont Health Technol Assess Ser; 2015; 15(18):1-45. PubMed ID: 26664664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
    Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Davidson B; Rodríguez-Perálvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Burroughs A
    Health Technol Assess; 2015 Jan; 19(9):1-409, v-vi. PubMed ID: 25633908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
    Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
    Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Singh S; Muir AJ; Dieterich DT; Falck-Ytter YT
    Gastroenterology; 2017 May; 152(6):1544-1577. PubMed ID: 28442120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.
    Friedrich-Rust M; Romen D; Vermehren J; Kriener S; Sadet D; Herrmann E; Zeuzem S; Bojunga J
    Eur J Radiol; 2012 Mar; 81(3):e325-31. PubMed ID: 22119555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
    Serra-Burriel M; Graupera I; Torán P; Thiele M; Roulot D; Wai-Sun Wong V; Neil Guha I; Fabrellas N; Arslanow A; Expósito C; Hernández R; Lai-Hung Wong G; Harman D; Darwish Murad S; Krag A; Pera G; Angeli P; Galle P; Aithal GP; Caballeria L; Castera L; Ginès P; Lammert F;
    J Hepatol; 2019 Dec; 71(6):1141-1151. PubMed ID: 31470067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound and FibroScan
    Salmi A; di Filippo L; Ferrari C; Frara S; Giustina A
    Endocrine; 2022 Nov; 78(2):262-269. PubMed ID: 35980569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A health technology assessment of transient elastography in adult liver disease.
    Steadman R; Myers RP; Leggett L; Lorenzetti D; Noseworthy T; Rose S; Sutherland L; Clement F
    Can J Gastroenterol; 2013 Mar; 27(3):149-58. PubMed ID: 23516679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients.
    Soto M; Sampietro-Colom L; Lasalvia L; Mira A; Jiménez W; Navasa M
    World J Gastroenterol; 2017 May; 23(17):3163-3173. PubMed ID: 28533673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of nonalcoholic steatohepatitis screening.
    Zhang E; Wartelle-Bladou C; Lepanto L; Lachaine J; Cloutier G; Tang A
    Eur Radiol; 2015 Nov; 25(11):3282-94. PubMed ID: 25994191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.
    Myers RP; Crotty P; Pomier-Layrargues G; Ma M; Urbanski SJ; Elkashab M
    Liver Int; 2010 Nov; 30(10):1471-80. PubMed ID: 20807336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis.
    Cai C; Song X; Chen X; Zhou W; Jin Q; Chen S; Ji F
    Can J Gastroenterol Hepatol; 2021; 2021():8859338. PubMed ID: 33542909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.